Publications

5538 Results

Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte-macrophage colony-stimulating factor fusion protein.

Authors
DE Hogge;CL Willman;RJ Kreitman;M Berger;PD Hall;KJ Kopecky;C McLain;EP Tagge;CJ Eaves;AE Frankel
Journal / Conference
Blood 92(2):589-595
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

Paclitaxel for the treatment of lymphoma.

Authors
A Younes
Journal / Conference
Journal of Clinical Oncology 16(6):2289-2290
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9246

Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (pts) with node-positive primary breast cancer (BC).

Authors
IC Henderson;D Berry;G Demetri;C Cirrincione;L Goldstein;S Martino;JN Ingle;MR Cooper;G Canellos;E Borden;G Fleming;JF Holland;S Graziano;J Carpenter;H Muss;L Norton
Journal / Conference
Proc of the American Society of Clinical Oncology 17:101a(#390a)
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9410 (INT-0148) (CALGB-9344)

Phase III intergroup trial of 13-cis-retinoic acid to prevent second primary tumors in stage-I non-small cell lung cancer (NSCLC): Interim report of NCI #191-0001.

Authors
SM Lippman;JJ Lee;DD Karp;EE Vokes;SE Benner;GE Goodman;C Kardinal;RJ Winn;JA Roth;WK Hong
Journal / Conference
Proc of the American Society of Clinical Oncology 17:456a(#1753)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9221 (MDACC, ID91-025) (INT-I91-0001)

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study.

Authors
CR Nichols;PJ Catalano;ED Crawford;NJ Vogelzang;LH Einhorn;PJ Loehrer
Journal / Conference
Journal of Clinical Oncology 16(4):1287-1293
Year
1998
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8997 (EST-3887) (ECOG-3887)

Fluorouracil (FU), leucovorin (LV), and levamisole (LEV) adjuvant therapy for colon cancer: Five-year final report of INT-0089.

Authors
DG Haller;PJ Catalano;JS Macdonald;RJ Mayer
Journal / Conference
Proc of the American Society of Clinical Oncology 17:256a(#982)
Year
1998
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8899 (INT-0089)

Interpreting clinical trials 2: Factorial designs, subset analyses, and intent to treat.

Authors
J Crowley
Journal / Conference
American Society of Clinical Oncology Education Book :253-259
Year
1998

Observations after 5 year follow-up of intergroup trial 0096: 4 cycles of cisplatin(P) etoposide (E) and concurrent 45 GY thoracic radiotherapy (TRT) given in daily (QD) or twice-daily fractions followed by 25 GY PCI. Survival differencs and patterns of failure.

Authors
A Turrisi;K Kim;W Sause;R Komaki;H Wagner;S Aisner;R Livingston;R Blum;D Johnson
Journal / Conference
Proc of the American Society of Clinical Oncology 17:457a(#1757
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)

Incidence and clinical significance of variant morphology (small cell/large cell subtype) in limited stage small cell lung cancer (SCLC). A prospective analysis of an intergroup ECOG, RTOG and SWOG study.

Authors
SC Aisner;A Turrisi;KM Kim;WT Sause;RB Livingston;L Einhorn;H Wagner;D Ettinger;R Komaki;R Blum;DH Johnson
Journal / Conference
Proc of the American Society of Clinical Oncology 17:458a(#1764)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)

Phase II trial of etoposide (V), ifosfamide (I) plus cisplatin (P) in patients with advanced thymoma (T) or thymic carcinoma (TC): Preliminary results from an ECOG coordinated intergroup trial.

Authors
PJ Loehrer;M Jiroutek;S Aisner;J Aisner;MR Greene;CR Thomas Jr;RB Livingston;DH Johnson
Journal / Conference
Proc of the American Society of Clinical Oncology 17:30a(#118)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9449 (INT-0156) (E1C93)